BGM

Qilian International Holding Group Limited is a prominent manufacturer and distributor of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives (TCMD) in China, strategically positioned to capitalize on the burgeoning demand for pharmaceutical advancements in the region. Headquartered in Jiuquan, the company boasts a robust operational framework and high-caliber production capabilities that serve both domestic and international markets. By combining modern technology with traditional medicinal knowledge, Qilian is leading the transformation within the pharmaceutical sector, presenting a compelling investment opportunity for institutional investors aiming to enhance their portfolios in the healthcare and biotechnology domains.